Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
David Livingston, PhD
Nicotinamide Mononucleotide in Patients with Alzheimer's Disease
David Livingston, PhD
MIB-626 FOR TREATMENT OF MILD DEMENTIA PATIENTS
A GuideStar-Rated Charity
© Copyright 2024. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).